Hosted on MSN18d
Dupilumab Proves Effective in Chronic Spontaneous UrticariaBOSTON -- Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) whose symptoms were uncontrolled with H1-antihistamine therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback